Literature DB >> 28338898

The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.

Takuya Yashiro1,2, Kazumi Kasakura1,2, Yoshihito Oda1, Nao Kitamura2, Akihito Inoue1, Shusuke Nakamura1, Hokuto Yokoyama2,3, Kanako Fukuyama2,3, Mutsuko Hara2, Hideoki Ogawa2, Ko Okumura2, Makoto Nishiyama3, Chiharu Nishiyama1,2.   

Abstract

PU.1 is a hematopoietic cell-specific transcription factor belonging to the Ets family, which plays an important role in the development of dendritic cells (DCs). CD11c (encoded by Itgax) is well established as a characteristic marker of hematopoietic lineages including DCs. In the present study, we analyzed the role of PU.1 (encoded by Spi-1) in the expression of CD11c. When small interfering RNA (siRNA) for Spi-1 was introduced into bone marrow-derived DCs (BMDCs), the mRNA level and cell surface expression of CD11c were dramatically reduced. Using reporter assays, the TTCC sequence at -56/-53 was identified to be critical for PU.1-mediated activation of the promoter. An EMSA showed that PU.1 directly bound to this region. ChIP assays demonstrated that a significant amount of PU.1 bound to this region on chromosomal DNA in BMDCs, which was decreased in LPS-stimulated BMDCs in accordance with the reduced levels of mRNAs of Itgax and Spi-1, and the histone acetylation degree. Enforced expression of exogenous PU.1 induced the expression of the CD11c protein on the cell surface of mast cells, whereas control transfectants rarely expressed CD11c. Quantitative RT-PCR also showed that the expression of a transcription factor Irf4, which is a partner molecule of PU.1, was reduced in PU.1-knocked down BMDCs. IRF4 transactivated the Itgax gene in a synergistic manner with PU.1. Taken together, these results indicate that PU.1 functions as a positive regulator of CD11c gene expression by directly binding to the Itgax promoter and through transactivation of the Irf4 gene. © The Japanese Society for Immunology. 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD11c/Itgax; IRF4/Irf4; PU.1/Spi-1; dendritic cell; transcription factor

Mesh:

Substances:

Year:  2017        PMID: 28338898     DOI: 10.1093/intimm/dxx009

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  4 in total

1.  T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1.

Authors:  Haichuan Zhu; Liuzhen Zhang; Yilin Wu; Bingjie Dong; Weilong Guo; Mei Wang; Lu Yang; Xiaoying Fan; Yuliang Tang; Ningshu Liu; Xiaoguang Lei; Hong Wu
Journal:  Elife       Date:  2018-11-09       Impact factor: 8.140

2.  Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus.

Authors:  David M Patrick; Néstor de la Visitación; Jaya Krishnan; Wei Chen; Michelle J Ormseth; C Michael Stein; Sean S Davies; Venkataraman Amarnath; Leslie J Crofford; Jonathan M Williams; Shilin Zhao; Charles D Smart; Sergey Dikalov; Anna Dikalova; Liang Xiao; Justin P Van Beusecum; Mingfang Ao; Agnes B Fogo; Annet Kirabo; David G Harrison
Journal:  JCI Insight       Date:  2022-07-08

3.  The effect of PU.1 knockdown on gene expression and function of mast cells.

Authors:  Yoshihito Oda; Kazumi Kasakura; Izumi Fujigaki; Azusa Kageyama; Ko Okumura; Hideoki Ogawa; Takuya Yashiro; Chiharu Nishiyama
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

4.  Logical modelling of in vitro differentiation of human monocytes into dendritic cells unravels novel transcriptional regulatory interactions.

Authors:  Karen J Nuñez-Reza; Aurélien Naldi; Arantza Sánchez-Jiménez; Ana V Leon-Apodaca; M Angélica Santana; Morgane Thomas-Chollier; Denis Thieffry; Alejandra Medina-Rivera
Journal:  Interface Focus       Date:  2021-06-11       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.